Publicly funded opioid abuse therapy costeffective in USA

Publicly funded opioid abuse therapy costeffective in USA PharmacoEconomics & Outcomes News 792, p25 - 2 Dec 2017 Publicly funded opioid abuse therapy cost effective in USA Publicly funded opioid abuse therapy (OAT) appears to be cost effective, according to findings of a US study published in Annals of Internal Medicine. A semi-Markov model was used to evaluate the cost effectiveness and budget impact of immediate access to opioid abuse therapy with methadone in a hypothetical population of patients 35 years of age with opioid abuse disorder (primarily due to heroin) presenting at publicly funded treatment centers in California, compared with the standard of care (short- term medically managed withdrawal), from a societal perspective over a lifetime time horizon. The model was populated with data from linked treatment and criminal justice administrative databases. Immediate access to opioid abuse therapy was estimated to gain 0.42 additional QALYs compared with the standard of care and to reduce total costs by $78 257 over a lifetime. Opioid abuse therapy was therefore dominant (more effective and less costly). It was estimated that treatment of all patients with opioid use disorder in California in 2014 with immediate opioid abuse therapy would achieve total lifetime savings $3.8 billion. Sensitivity analysis found that opioid abuse therapy was cost effective in 99.6% of simulations. "Our findings further underline the need for widespread and unencumbered access to evidence- based treatment of opioid use disorder to reduce the burden to society of the current prescription opioid and heroin use epidemic," the authors commented. * 2016 US dollars Krebs E, et al. Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California Annals of Internal Medicine : 21 Nov 2017. Available from: URL: http://doi.org/10.7326/M17-0611 803284965 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

Publicly funded opioid abuse therapy costeffective in USA

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/publicly-funded-opioid-abuse-therapy-costeffective-in-usa-lXxFqzhXqc
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
D.O.I.
10.1007/s40274-017-4548-9
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics & Outcomes News 792, p25 - 2 Dec 2017 Publicly funded opioid abuse therapy cost effective in USA Publicly funded opioid abuse therapy (OAT) appears to be cost effective, according to findings of a US study published in Annals of Internal Medicine. A semi-Markov model was used to evaluate the cost effectiveness and budget impact of immediate access to opioid abuse therapy with methadone in a hypothetical population of patients 35 years of age with opioid abuse disorder (primarily due to heroin) presenting at publicly funded treatment centers in California, compared with the standard of care (short- term medically managed withdrawal), from a societal perspective over a lifetime time horizon. The model was populated with data from linked treatment and criminal justice administrative databases. Immediate access to opioid abuse therapy was estimated to gain 0.42 additional QALYs compared with the standard of care and to reduce total costs by $78 257 over a lifetime. Opioid abuse therapy was therefore dominant (more effective and less costly). It was estimated that treatment of all patients with opioid use disorder in California in 2014 with immediate opioid abuse therapy would achieve total lifetime savings $3.8 billion. Sensitivity analysis found that opioid abuse therapy was cost effective in 99.6% of simulations. "Our findings further underline the need for widespread and unencumbered access to evidence- based treatment of opioid use disorder to reduce the burden to society of the current prescription opioid and heroin use epidemic," the authors commented. * 2016 US dollars Krebs E, et al. Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California Annals of Internal Medicine : 21 Nov 2017. Available from: URL: http://doi.org/10.7326/M17-0611 803284965 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792

Journal

PharmacoEconomics & Outcomes NewsSpringer Journals

Published: Dec 2, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off